PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH
用途生物活性体外研究体内研究 用途与合成方法 MSDS PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH价格(试剂级) 上下游产品信息
| 中文名称 | PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH |
|---|---|
| 中文同义词 | S-[2,3-二[(1-氧代十六烷基)氧基]丙基]-N-(1-氧代十六烷基)-L-半胱氨酰基-L-丝氨酰基-L-赖氨酰基-L-赖氨酰基-L-赖氨酰基-L-赖氨酸;PAM?CYS-SER-(LYS)?,盐酸盐;(2S)-6-AMINO-2-[[(2S)-6-AMINO-2-[[(2S)-6-AMINO-2-[[(2S)-6-AMINO-2-[[(2S)-2-[[(2R)-3-[2,3-DI(HEXADECANOYLOXY)PROPYLSULFANYL]-2-(HEXADECANOYLAMINO)PROPANOYL]AMINO]-3-HYDROXYPROPANOYL]AMINO]HEXANOYL]AMINO]HEXANOYL]AMINO]HEXANOYL]AMINO]HEXANOIC ACID;白介素-1样受体蛋白激动剂(含硫化合物);(2S,5S,8S,11S,14S,17R)-2,5,8,11-四(4-氨基丁基)-14-(羟甲基)-4,7,10,13,16,24-六氧代-17-十六酰胺-21-(十六酰氧基)-23-氧杂-19-硫杂-3,6,9,12,15-五氮杂三十九烷-1-甲酸;三酰脂肽;PALMITOYLCYS((RS)2,3DI(PALMITOYLOXY)PROPYL)SKKKK-OH (TRIFLUOROACETATE SALT) |
| 英文名称 | PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH |
| 英文同义词 | PAM3-CYS-SER-LYS-LYS-LYS-LYS-OH;PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH;n-palmitoyl-s-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-ly;sine;N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine;PaM3Cys-Ser-Lys-Lys-Lys-Lys-OH, PaM3CSK4;PaM3Cys-Ser-(Lys)4 . 3HCl;P 3C |
| CAS号 | 112208-00-1 |
| 分子式 | C81H156N10O13S |
| 分子量 | 1510.23 |
| EINECS号 | |
| 相关类别 | 化合物;标准品;Pharmaceutical |
| Mol文件 | 112208-00-1.mol |
| 结构式 |  |
PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH 性质
| 沸点 | 1408.0±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.054±0.06 g/cm3(Predicted) |
| 储存条件 | -15°C |
| 溶解度 | 在 50% 乙醇/水中的溶解度为 1 mg/ml |
| 形态 | 冻干固体 |
| 酸度系数(pKa) | 3.27±0.10(Predicted) |
本品主要用于实验室有机合成中和化工医药研发过程中。Pam3CSK4 是一种 Toll 样受体 1/2 (TLR1/2) 激动剂，对人 TLR1/2 的 EC50 为 0.47 ng/mL。
Pam3CSK4 is a TLR1/2 heterodimer recognises triacylated lipopeptides.
Pam3CSK4 (1 μg/mL) enhances the antibacterial functions of granulocyte macrophage-colony stimulating factor (GM-CSF) induced neutrophils to Methicillin-resistant
Staphylococcus aureus
.
Pam3CSK4 (5 mg/kg; i.p.; once a day for 9 days) alters brain, spleen and liver weights in neonatal mice.
| Animal Model: | Time-mated pregnant C57BL/6 wild-type mice; B6.129-Tlr2 tm1Kir /J (TLR2 -deficient) mice |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneally (i.p.); once a day for 9 days |
| Result: | After repeated administration from postnatal day (PND3) to PND11, brain weight was decreased compared with endotoxin-free saline-treated animals at PND12. Decreased volume of cerebral gray matter, white matter in the forebrain and cerebellar molecular layer that was accompanied by an increase in spleen and liver weight at PND12. |
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2022/04/29 | HY-P1180 | PALMITOYL-CYS((RS)-2,3-DI(PALMITOYLOXY)-PROPYL)-SER-LYS-LYS-LYS-LYS-OH Pam3CSK4 | 112208-00-1 | 1mg | 6800元 |